通过调节TGFβ/Smads和NF-κB信号通路,HDAC6参与糖尿病病
Jialin Li1, Jiawen Zhang2, Xiaocui Huang2
1Jiangxi Province Key Laboratory of Pharmacology of Traditional Chinese Medicine, Gannan Medical University, Ganzhou 341000, China; School of Pharmacy, Gannan Medical University, Ganzhou 341000, China; Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou 341000, China.
基斯脱乙酶6 (HDAC6) 在糖尿病病 (DN) 中被上调. 抑制HDAC6通过通过Smad7.7调节TGF-β/Smads和NF-κB通路来减少纤维化和炎症.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 糖尿病病 (DN) 涉及复杂的信号通路.
- 基因组脱乙酶6 (HDAC6) 在DN病变发生中的作用尚不清楚.
- TGF-β/Smads和NF-κB通路介于DNA中的纤维化和炎症.
研究的目的:
- 研究HDAC6在DN中的作用.
- 阐明HDAC6在DN病变发生过程中的机制.
- 确定HDAC6对TGF-β/Smads和NF-κB信号传导的影响.
主要方法:
- 已建立的糖尿病细胞和动物模型.
- 使用高葡萄糖和高脂肪饮食与STZ注射.
- 使用HDAC6抑制 (ACY1215) 和基因沉默 (siRNA).
- 评估路径激活和纤维化/炎症标志物.
主要成果:
- 在DN模型中,HDAC6是上调的.
- 抑制HDAC6的抑制/沉默抑制了TGF-β/Smads和NF-κB通路.
- 在HDAC6抑制后观察到的减少纤维化和炎症.
- 过度表达HDAC6增加了纤维化标志物和减少了Smad7.
结论:
- HDAC6涉及DN病原和进展.
- HDAC6调节TGF-β/Smads和NF-κB的信号通路.
- HDAC6通过Smad7.7的调制来影响DN.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
相关概念视频
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
